STAT4d
The company also agreed to pay $70 million to settle a whistleblower lawsuit
After protracted legal battling, GSK has agreed to pay up to $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer.
Wall Street Journal3d
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
The British pharmaceutical giant said Wednesday that it had struck agreements with 10 plaintiff firms aimed at resolving 93%, or about 80,000, of pending Zantac lawsuits in the country for up to ...
FiercePharma3d
GSK will pony up $2.2B to resolve 80K Zantac cases
GSK has agreed to pay up to $2.2 billion to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer. The agreement frees the British ...
GSK to Resolve 93% of U.S. State Court Zantac Product Liability Cases for Up to $2.2B
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...